UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Updates in combined approaches of radiotherapy and immune checkpoint inhibitors for the treatment of breast cancer

Frontiers in oncology, 2022-10, Vol.12, p.1022542-1022542

2022

Volltextzugriff (PDF)

RB expression confers sensitivity to CDK4/6 inhibitor-mediated radiosensitization across breast cancer subtypes

JCI insight, 2022-02, Vol.7 (3)

2022

Volltextzugriff (PDF)

When Old Becomes New—Repurposing Cytotoxic Chemotherapy With Radiation to Improve Outcomes in Women With Aggressive Forms of Breast Cancer

International journal of radiation oncology, biology, physics, 2021-09, Vol.111 (1), p.53-55

2021

Volltextzugriff (PDF)

Estrogen receptor inhibition mediates radiosensitization of ER-positive breast cancer models

NPJ breast cancer, 2022-03, Vol.8 (1), p.31-31, Article 31

2022

Volltextzugriff (PDF)

Development and Validation of a Genomic Profile for the Omission of Local Adjuvant Radiation in Breast Cancer

Journal of clinical oncology, 2023-03, Vol.41 (8), p.1533-1540

2023

Volltextzugriff (PDF)

Clinicogenomic Radiotherapy Classifier Predicting the Need for Intensified Locoregional Treatment After Breast-Conserving Surgery for Early-Stage Breast Cancer

Journal of clinical oncology, 2019-12, Vol.37 (35), p.3340-3349

2019

Volltextzugriff (PDF)

Publisher Correction: Estrogen receptor inhibition mediates radiosensitization of ER-positive breast cancer models

NPJ breast cancer, 2022-04, Vol.8 (1), p.54-54, Article 54

2022

Volltextzugriff (PDF)

ARe we there yet? Understanding androgen receptor signaling in breast cancer

NPJ breast cancer, 2020-09, Vol.6 (1), p.47-47, Article 47

2020

Volltextzugriff (PDF)

Evaluation of the Sensitivity to Endocrine Therapy Index and 21-Gene Breast Recurrence Score in the SWOG S8814 Trial

Journal of clinical oncology, 2023-04, Vol.41 (10), p.1841-1848

2023

Volltextzugriff (PDF)

Short-term CDK4/6 Inhibition Radiosensitizes Estrogen Receptor-Positive Breast Cancers

Clinical cancer research, 2020-12, Vol.26 (24), p.6568-6580

2020

Volltextzugriff (PDF)

Comprehensive Transcriptomic Profiling Identifies Breast Cancer Patients Who May Be Spared Adjuvant Systemic Therapy

Clinical cancer research, 2020-01, Vol.26 (1), p.171-182

2020

Volltextzugriff (PDF)

Integrating Tumor-Intrinsic and Immunologic Factors to Identify Immunogenic Breast Cancers from a Low-Risk Cohort: Results from the Randomized SweBCG91RT Trial

Clinical cancer research, 2023-05, Vol.29 (9), p.1783-1793

2023

Volltextzugriff (PDF)

The Role of Circulating Tumor Cells in Breast Cancer and Implications for Radiation Treatment Decisions

International journal of radiation oncology, biology, physics, 2021-01, Vol.109 (1), p.44-59

2021

Volltextzugriff (PDF)

Androgen and oestrogen receptor co-expression determines the efficacy of hormone receptor-mediated radiosensitisation in breast cancer

British journal of cancer, 2022-09, Vol.127 (5), p.927-936

2022

Volltextzugriff (PDF)

Inhibition of the p38 Kinase Suppresses the Proliferation of Human ER-Negative Breast Cancer Cells

Cancer research (Chicago, Ill.), 2009-12, Vol.69 (23), p.8853-8861

2009

Volltextzugriff (PDF)

Modulating the Radiation Response for Improved Outcomes in Breast Cancer

JCO precision oncology, 2021, Vol.5 (5), p.245-264

2021

Volltextzugriff (PDF)

Xenograft-based, platform-independent gene signatures to predict response to alkylating chemotherapy, radiation, and combination therapy for glioblastoma

Neuro-oncology (Charlottesville, Va.), 2019-09, Vol.21 (9), p.1141-1149

2019

Volltextzugriff (PDF)

Bcl-xL inhibition radiosensitizes PIK3CA/PTEN wild-type triple negative breast cancers with low Mcl-1 expression

Cancer research communications, 2022-07, Vol.2 (7), p.679-693

2022

Volltextzugriff (PDF)

Post-Mastectomy Radiation Therapy: Applications and Advancements

Current breast cancer reports, 2022-09, Vol.14 (3), p.75-82

2022

Volltextzugriff (PDF)

Regional Nodal Radiotherapy in Early-Stage Breast Cancer: Where Are We in 2016?

Current breast cancer reports, 2016-06, Vol.8 (2), p.95-104

2016

Volltextzugriff (PDF)

Subclonal evolution and expansion of spatially distinct THY1-positive cells is associated with recurrence in glioblastoma

Neoplasia (New York, N.Y.), 2023-02, Vol.36, p.100872, Article 100872

2023

Volltextzugriff (PDF)

Optimizing Radiation Therapy to Boost Systemic Immune Responses in Breast Cancer: A Critical Review for Breast Radiation Oncologists

International journal of radiation oncology, biology, physics, 2020-09, Vol.108 (1), p.227-241

2020

Volltextzugriff (PDF)

1 – 22 von 22

Suche als RSS-Feed

Aktive Filter

ThemaOncology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(22)
Mit Volltextzugriff
(19)

Publikationsform

Artikel
(22)

Sprache

Englisch
(22)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Updates in combined approaches of radiotherapy and immune checkpoint inhibitors for the treatment of breast cancer

RB expression confers sensitivity to CDK4/6 inhibitor-mediated radiosensitization across breast cancer subtypes

When Old Becomes New—Repurposing Cytotoxic Chemotherapy With Radiation to Improve Outcomes in Women With Aggressive Forms of Breast Cancer

Estrogen receptor inhibition mediates radiosensitization of ER-positive breast cancer models

Development and Validation of a Genomic Profile for the Omission of Local Adjuvant Radiation in Breast Cancer

Clinicogenomic Radiotherapy Classifier Predicting the Need for Intensified Locoregional Treatment After Breast-Conserving Surgery for Early-Stage Breast Cancer

Publisher Correction: Estrogen receptor inhibition mediates radiosensitization of ER-positive breast cancer models

ARe we there yet? Understanding androgen receptor signaling in breast cancer

Evaluation of the Sensitivity to Endocrine Therapy Index and 21-Gene Breast Recurrence Score in the SWOG S8814 Trial

Short-term CDK4/6 Inhibition Radiosensitizes Estrogen Receptor-Positive Breast Cancers

Comprehensive Transcriptomic Profiling Identifies Breast Cancer Patients Who May Be Spared Adjuvant Systemic Therapy

Integrating Tumor-Intrinsic and Immunologic Factors to Identify Immunogenic Breast Cancers from a Low-Risk Cohort: Results from the Randomized SweBCG91RT Trial

The Role of Circulating Tumor Cells in Breast Cancer and Implications for Radiation Treatment Decisions

Androgen and oestrogen receptor co-expression determines the efficacy of hormone receptor-mediated radiosensitisation in breast cancer

Inhibition of the p38 Kinase Suppresses the Proliferation of Human ER-Negative Breast Cancer Cells

Modulating the Radiation Response for Improved Outcomes in Breast Cancer

Xenograft-based, platform-independent gene signatures to predict response to alkylating chemotherapy, radiation, and combination therapy for glioblastoma

Bcl-xL inhibition radiosensitizes PIK3CA/PTEN wild-type triple negative breast cancers with low Mcl-1 expression

Post-Mastectomy Radiation Therapy: Applications and Advancements

Regional Nodal Radiotherapy in Early-Stage Breast Cancer: Where Are We in 2016?

Subclonal evolution and expansion of spatially distinct THY1-positive cells is associated with recurrence in glioblastoma

Optimizing Radiation Therapy to Boost Systemic Immune Responses in Breast Cancer: A Critical Review for Breast Radiation Oncologists

Aktive Filter

Suchergebnisse filtern